{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:42:01Z","timestamp":1790851321159,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ophtha.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T23:08:17Z","timestamp":1466291297000},"page":"1999-2003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis"],"prefix":"10.1016","volume":"123","author":[{"given":"John J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Warrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.ejim.2009.07.017","article-title":"Clinical manifestations and laboratory tests in biopsy proven giant cell arteritis in Glasgow","volume":"20","author":"Aziz","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ophtha.2016.05.008_bib3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2016.05.008_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejim.2008.07.030","article-title":"Epidemiological and clinical features of giant cell arteritis in Tunisia","volume":"20","author":"Khalifa","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ophtha.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2005.06.011","article-title":"Giant cell (temporal) arteritis: an overview and update","volume":"50","author":"Rahman","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.05.008_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.1780240706","article-title":"The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications","volume":"24","author":"Bengtsson","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/art.1780230605","article-title":"Presentation of occult giant cell arteritis","volume":"23","author":"Healey","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0954-6820.1977.tb15683.x","article-title":"Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients","volume":"201","author":"Sorensen","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ophtha.2016.05.008_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2016.05.008_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","article-title":"Prognosis in giant-cell arteritis","volume":"282","author":"Graham","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ophtha.2016.05.008_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780370705","article-title":"Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis","volume":"37","author":"Baldursson","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.05.008_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/scientificamerican1081-54","article-title":"The patient record in epidemiology","volume":"245","author":"Kurland","year":"1981","journal-title":"Sci Am"},{"key":"10.1016\/j.ophtha.2016.05.008_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ophtha.2016.05.008_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.05.008_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","article-title":"Simple rule for calculating normal erythrocyte sedimentation rate","volume":"286","author":"Miller","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ophtha.2016.05.008_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ophtha.2016.05.008_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2016.05.008_bib26","first-page":"249","article-title":"The ocular lesions of temporal arteritis","volume":"55","author":"Wagener","year":"1957","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2016.05.008_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2016.05.008_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009","volume":"44","author":"Chandran","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ophtha.2016.05.008_bib31","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2016.05.008_bib32","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(03)00228-8","article-title":"Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy","volume":"110","author":"Hayreh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.05.008_bib33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ophtha.2016.05.008_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ceo.12069","article-title":"Giant cell arteritis incidence: analysis by season and year in mid-Atlantic United States","volume":"41","author":"Kisza","year":"2013","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016303074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016303074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:25:59Z","timestamp":1536625559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016303074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0161642016303074"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.05.008","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}